Twin Tree Management, LP Invitae Corp Put Options Transaction History

Twin Tree Management, LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 11, 2022	SELL	$6.28 - $15.59 $1,884 - $4,677	-300 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$14.7 - $28.67 $2,940 - $5,734	200 Added 200.0%	300 $5,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $2,431 - $3,360	100 New	100 $3,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $448,748 - $694,880	-17,200 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $8.67 Million - $14.9 Million	-262,300 Reduced 93.85%	17,200 $657,000
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $10.9 Million - $16 Million	279,500 New	279,500 $11.7 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.